Yuanjin Zhang | Medicine | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Yuanjin Zhang | Medicine | Best Researcher Award

Peking University Third Hospital | China

Dr. Yuanjin Zhang is a distinguished neurologist and chief physician at Peking University Third Hospital, recognized for her pioneering work in neurotherapeutics, neurodegeneration, and digital medicine. Educated and trained at Peking University Health Science Center, she combines strong clinical expertise with innovative research in amyotrophic lateral sclerosis, neuropathic pain, and AI-driven healthcare technologies. Her professional journey bridges academic medicine and industry, where she has led numerous multi-center clinical and translational projects focused on diabetic neuropathy, stroke, and cognitive disorders. Dr. Zhang’s research interests encompass neurological and vascular sciences, digital biomarkers, mHealth platforms, and precision neurorehabilitation. She possesses advanced skills in clinical data analytics, bioinformatics, AI algorithm development, and translational neurotechnology, supported by extensive NIH and NSFC-funded collaborations. Her contributions to journals such as BMC Neurology, Scientific Reports, and JMIR MHealth UHealth highlight her global impact on digital neurotherapeutics. As a reviewer for leading journals and an active member of national neurology and neuroscience societies, she promotes interdisciplinary collaboration across China’s medical and research communities. Honored for her leadership and scientific innovation, Dr. Zhang continues to shape the future of neurology through AI-enabled clinical care and patient-centered neurotechnology, embodying excellence in research, mentorship, and translational impact.

Profile: ORCID

Featured Publications

Mohamed Taha Moutaoufik | Neurodegenerative Diseases | Best Research Article Award

Published on by Cognitive Scientist Awards

Prof. Mohamed Taha Moutaoufik | Neurodegenerative Diseases | Best Research Article Award

Mohammed VI Polytechnic University | Morocco

Dr. Mohamed Taha Moutaoufik is an accomplished Moroccan molecular biologist and Assistant Professor at the University Mohammed VI Polytechnic, with a strong foundation in cell and molecular biology acquired through advanced studies at Université Laval and Université Ibn Zohr. His professional experience spans roles as a Research Associate and Postdoctoral Fellow at the University of Regina in Canada, where he contributed to cutting-edge research on protein interactions, mitochondrial biology, and neurodegenerative disease mechanisms. His scholarly involvement includes memberships in prestigious societies such as the Human Proteome Organization and the Mediterranean Neuroscience Society. Dr. Moutaoufik’s research interests center on proteomics, neurodegeneration, mitochondrial interactomes, and molecular mechanisms underlying Parkinson’s and Huntington’s diseases. He demonstrates expertise in multi-omics data integration, bioinformatics, protein-protein interaction mapping, and advanced molecular techniques. As an editor for Frontiers in Chemistry and related journals, he has overseen significant contributions to molecular biosciences. His numerous awards, including fellowships from the Canadian Institutes of Health Research and Parkinson Canada, reflect his research excellence and leadership in biomedical science. Overall, Dr. Moutaoufik exemplifies a dynamic researcher whose interdisciplinary work bridges molecular biology and neuroproteomics, advancing scientific understanding of cellular mechanisms and their implications for precision medicine.

Profile: ORCID

Featured Publications

Alina Diana Zamfir | Brain Science | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Dr. Alina Diana Zamfir | Brain Science | Best Researcher Award

National Institute for R&D in Electrochemistry and Condensed Matter | Romania

Dr. Alina Diana Zamfir is a distinguished Romanian physicist and professor known for her pioneering research in biophysics, mass spectrometry, and biomolecular analysis. She earned her academic degrees in physics from leading Romanian universities, including a Ph.D. in Physics and two habilitations in Biophysics and Physics from prestigious institutions in Romania and Germany. Currently serving as a Senior Scientific Researcher at the National Institute for Research and Development in Electrochemistry and Condensed Matter and as a Professor at Aurel Vlaicu University of Arad, she also mentors doctoral candidates at the West University of Timisoara. Her professional journey includes research and teaching appointments in Germany and collaborations with international universities and corporations. Dr. Zamfir’s research interests focus on mass spectrometry-based proteomics, glycomics, and microfluidics for the analysis of complex biological systems. She is highly skilled in advanced spectrometric analysis, microfluidic platform development, and molecular characterization of biomolecules. A recipient of numerous awards, including the Romanian Academy Prize, the Elsevier Top Cited Article Award, and the Wiley Award, she is also President of the Romanian Society for Mass Spectrometry. Her extensive contributions to molecular biophysics and analytical chemistry continue to advance biomedical innovation and interdisciplinary scientific excellence worldwide.

Profile: Google scholar

Featured Publications

Jaime Charris | Medicinal Chemistry | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Jaime Charris | Medicinal Chemistry | Best Researcher Award

Central University of Venezuela | Venezuela

Jaime Enrique Charris Charris is a distinguished medicinal chemist from the Faculty of Pharmacy at the Central University of Venezuela, recognized for his contributions to organic synthesis, drug design, and spectroscopic methods applied to the development of molecules with anticancer and antiparasitic potential. He holds academic training in pharmaceutical sciences, medicinal chemistry, and a doctoral degree in the same field, complemented by postdoctoral research experiences in leading institutions in the United States and France. His professional trajectory includes decades of service as a professor, researcher, and academic leader, where he directed divisions, postgraduate programs, and research initiatives within his faculty, eventually attaining emeritus status. His research interests focus on the design, synthesis, and biological evaluation of heterocyclic compounds, hybrids, and functionalized derivatives for the treatment of diseases such as Chagas, leishmaniasis, malaria, and various cancers, with skills spanning synthetic chemistry, in silico ADMET profiling, pharmacological assays, and drug repurposing strategies. He has guided doctoral research, secured national research grants, and published extensively in international journals. His work has been recognized with prestigious awards, including distinctions from scientific foundations, academic institutions, and national science ministries. In conclusion, Dr. Charris combines scientific rigor, innovation, and leadership in medicinal chemistry, positioning himself as a prominent figure advancing therapeutic discovery in Latin America and beyond.

Profile: Google scholar

Featured Publications

Natalia N. Kudryavtseva | Neurobiology | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Dr. Natalia N. Kudryavtseva | Neurobiology | Best Researcher Award

Institute of Cytology and Genetics of SB RAS | Russia

Professor Natalia N. Kudryavtseva is a highly distinguished neuroscientist and leading researcher at the I.P. Pavlov Institute of Physiology RAS in Saint Petersburg and the Institute of Cytology and Genetics SB RAS in Novosibirsk, with extensive academic and research contributions in behavioral pharmacology, neurogenetics, and biological psychiatry. She completed her education at Novosibirsk State University in physiology and advanced to hold key positions as junior, senior, and leading researcher, later becoming head of the Neurogenetics of Social Behaviour Sector and the Neuropathology Modelling Laboratory. Her professional journey includes visiting research at Cold Spring Harbor Laboratory in the United States, along with teaching as professor of physiology at Novosibirsk State University. Her research interests span behavioral genetics, social biology, psychopharmacology, transcriptomic analysis, and modelling of psychoemotional disorders, particularly through the sensory contact model she developed, widely applied in the study of chronic social conflict and neuropsychiatric mechanisms. She is skilled in neurogenomics, experimental neurobiology, and psychopharmacological correction, with more than one hundred eighty publications and several books. She is an active member of international research societies and has collaborated with institutions across Europe and the USA. Recognized for her pioneering contributions, with a citation index exceeding four thousand and an h-index of thirty-seven, she has received numerous honors for advancing knowledge on the neurobiology of aggression and psychoemotional disorders, making her a truly deserving candidate for international recognition.

Profile: ORCID

Featured Publications

Jing Zhang | Medicinal Chemistry | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Jing Zhang | Medicinal Chemistry | Best Researcher Award

School of Life Sciences and Engineering | China

Dr. Jing Zhang, currently a lecturer at the School of Life Sciences and Engineering, Lanzhou University of Technology, is a dedicated scholar with a strong academic foundation built at Wuhan University, where she completed her bachelor’s and master’s studies in pharmaceutical sciences and medicinal chemistry and later earned a doctorate in pharmaceutical sciences. Her professional journey includes valuable research experience as a research intern at the Chinese Academy of Sciences in the Department of Magnetic Resonance Imaging, which enhanced her expertise in imaging technologies and drug delivery systems. Her research interests lie in the fields of nanomedicine, drug delivery, photodynamic and photothermal therapies, fluorine-based magnetic resonance imaging, and cancer therapeutics. She has contributed significantly to these domains through publications in high-impact journals such as Chemistry & Biodiversity, Advanced Healthcare Materials, The Journal of Organic Chemistry, and Chemical Communications, focusing on anticancer agents, traceable biomaterials, and estrogen receptor modulators. Dr. Zhang’s research skills span organic synthesis, polymer chemistry, molecular imaging, and the development of multifunctional nanocarriers for cancer treatment. Her achievements are further supported by prestigious research funding, including national and provincial projects and collaborations with pharmaceutical industries. Recognized for her diligence and truth-seeking approach, she continues to advance biomedical innovation with the potential to impact cancer diagnosis and therapy significantly, making her a promising leader in pharmaceutical sciences.

Profile: ORCID

Featured Publications

Yu-Young Lee | Natural Product-based Neuropharmacology | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Yu-Young Lee | Natural Product-Based Neuropharmacology | Best Researcher Award

National Institute of Crop Science | South Korea

Dr. Yu-Young Lee is a distinguished scientist at the National Institute of Crop Science, Rural Development Administration, Korea, with a specialization in the chemistry of natural products and crop quality evaluation. Her career reflects a deep commitment to advancing agricultural sciences, particularly in improving the nutritional and functional value of food crops through innovative biochemical approaches. She has significantly contributed to research on soybeans, oats, wheat, rice, and peanuts, focusing on bioactive compounds and their roles in human health. With her extensive international collaborations, including research experiences at the USDA and Tufts University, she has established herself as a global leader in agricultural biochemistry and crop quality science. Her numerous publications in peer-reviewed journals showcase her expertise in natural product chemistry, food functionality, and crop science. Through her research, Dr. Lee continues to bridge the gap between agriculture and human nutrition, aiming to improve both food quality and global health.

Profile

Scopus

Education

Dr. Yu-Young Lee pursued her academic journey at Kyungpook National University, Daegu, Korea, where she completed her studies in agricultural biology and life sciences. She earned her Bachelor’s degree in Agricultural Biology, building a solid foundation in crop science and plant research. She then advanced her studies by completing a Master’s degree in Agriculture and Life Science, focusing her research on the isolation of oleanane triterpenes and trans-resveratrol from the root of peanuts, highlighting her early interest in natural products and bioactive compounds. Her academic path culminated in a Ph.D. in Agriculture and Life Science, where she concentrated on the development of tocochromanol compound-enhanced soybeans and the evaluation of their biological activities. This advanced work demonstrated her pioneering vision of integrating crop science with health-promoting biochemical innovations. Her educational background reflects her dedication to merging agricultural productivity with food science to enhance nutritional and functional values of crops.

Experience

Dr. Yu-Young Lee has built a distinguished career as a scientist at the National Institute of Crop Science, Rural Development Administration, Korea, where she has contributed extensively to crop quality research and evaluation. Her role encompasses investigating natural compounds in crops and developing methods to enhance their nutritional and functional properties. She has conducted international research as an invited scientist at the Human Nutrition Research Center on Aging at Tufts University and at the Soft Wheat Quality Laboratory at USDA-ARS, gaining global perspectives on agricultural and nutritional sciences. Her research extends across multiple crops, including soybeans, oats, wheat, rice, and peanuts, where she explores bioactive compounds and their potential benefits for human health. She has led and collaborated on numerous projects focusing on food quality, safety, and functionality, establishing herself as a trusted authority in agricultural biochemistry and crop research. Her professional journey reflects a balance of national service and global collaboration.

Awards and Honors

Dr. Yu-Young Lee’s outstanding contributions to agricultural science and natural product chemistry have earned her recognition within Korea and internationally. Her invited appointments as a visiting scientist at world-renowned institutions such as Tufts University and the USDA-ARS underscore her respected position in the global research community. She has received honors through research collaborations and publications in high-impact journals, reflecting her strong academic and scientific reputation. Her work on enhancing soybean, oat, and rice quality with bioactive compounds has been widely acknowledged for its originality and relevance to both food science and human health. She has been instrumental in developing innovative methodologies for analyzing crop quality, which has advanced national agricultural programs. By bridging crop science and nutrition, her work has supported food security initiatives while improving the value of staple crops. Her career stands as a testament to her dedication, excellence, and the impact of her scientific endeavors.

Research Focus

Dr. Lee’s research focuses on the chemistry of natural products and their application in improving crop quality and human health. She investigates bioactive compounds such as tocochromanols, avenanthramides, polyphenols, and triterpenes, aiming to enhance the nutritional and functional value of staple crops. Her studies span multiple crops, including soybeans, oats, rice, wheat, and peanuts, where she analyzes their biochemical properties, antioxidant potential, and biological effects. A key aspect of her work is developing functional foods through biochemical enrichment, such as tocochromanol-enhanced soybeans and germinated oat extracts with neuroprotective effects. She also explores food processing methods, post-harvest improvements, and crop germplasm evaluation to optimize both quality and safety. Her interdisciplinary approach integrates agricultural science, plant biochemistry, and nutritional research, making her contributions vital to global health and food security. By linking agricultural outputs with human well-being, she pioneers innovative strategies for functional crop development and sustainable food systems.

 

Publications

 

Title: Standardization of Germinated Oat Extracts and Their Neuroprotective Effects Against Aβ1-42 Induced Cytotoxicity in SH-SY5Y Cells
Year: 2025

Title: Oat Extract Avenanthramide-C Reverses Hippocampal Long-Term Potentiation Decline in Tg2576 Mice
Year: 2021

Title: Oat (Avena sativa) Extract against Oxidative Stress-Induced Apoptosis in Human Keratinocytes
Year: 2021

Title: Influences of hydrothermal and pressure treatments on compositional and hydration properties of wheat bran and dough mixing properties of whole wheat meal
Year: 2021

Title: Development of Nano Soy Milk through Sensory Attributes and Consumer Acceptability
Year: 2021

Title: Avenanthramide-C Restores Impaired Plasticity and Cognition in Alzheimer’s Disease Model Mice
Year: 2020

Title: Oat germination and ultrafiltration process improves the polyphenol and avenanthramide contents with protective effect in oxidative damaged HepG2 cells
Year: 2019

Title: Physicochemical and antioxidant properties of rice cooked with different proportions of black soybeans and cooking methods
Year: 2018

Title: Assessment of microbial safety and quality changes of brown and white cooked rice treated with atmospheric pressure plasma
Year: 2018

Title: Black soybeans protect human keratinocytes from oxidative stress-induced cell death
Year: 2018

Conclusion

Dr. Yu-Young Lee is a pioneering agricultural scientist whose expertise in natural product chemistry, crop quality enhancement, and functional food development continues to make a profound impact on global agriculture and human nutrition.

Sarah Leibowitz | Behavioral Neurobiology | Most Cited Article Award

Published on by Cognitive Scientist Awards

Dr. Sarah Leibowitz | Behavioral Neurobiology | Most Cited Article Award

The Rockefeller University | United States

Dr. Sarah F. Leibowitz is a Research Associate Professor at The Rockefeller University in the Laboratory of Behavioral Neurobiology. With a career dedicated to uncovering the neural basis of addiction, she focuses on how the brain regulates consumption of substances like alcohol and nicotine, as well as high-fat and high-sugar foods. Her pioneering work explores the transition from casual intake to substance dependence, linking specific brain mechanisms to addictive behaviors. Dr. Leibowitz’s research also highlights how emotional traits—such as impulsivity and anxiety—influence substance use. In recent years, she has expanded her work to investigate how maternal diet and drug exposure during pregnancy affect the brain development and behavior of offspring. Her studies reveal persistent neural and behavioral changes that may increase vulnerability to addiction later in life. Through her research, she aims to identify early indicators of addiction risk and explore preventive strategies for substance abuse disorders.

Profile

ORCID

Education

Dr. Sarah F. Leibowitz earned her Ph.D. in behavioral neurobiology, establishing her foundation in neuroscience and psychobiology. Although specific details of her academic institutions are not publicly disclosed, her academic trajectory clearly reflects rigorous training in neurobiology, endocrinology, and developmental neuroscience. Her education emphasized the interplay between brain structure, behavior, and environmental stimuli—especially as related to addiction and nutrition. Over the course of her doctoral and postdoctoral work, she developed specialized expertise in rodent models, neurochemical techniques, and behavioral neuroscience. Her educational background has equipped her to contribute significantly to the understanding of the neural mechanisms underlying addiction, impulsivity, and maternal influences on brain development. Dr. Leibowitz’s academic formation has not only shaped her robust research career but also positioned her as a mentor and thought leader in the intersection of behavioral neuroscience, addiction research, and developmental psychobiology.

 Experience

Dr. Sarah Leibowitz brings decades of experience in behavioral neuroscience, serving as a Research Associate Professor at The Rockefeller University. In this role, she leads research exploring how neurochemical circuits in the brain influence the consumption of addictive substances and palatable foods. Her experience spans experimental neurobiology, developmental studies, and translational addiction research, using advanced rodent models to simulate human behavioral patterns. She has worked extensively on characterizing the neural pathways that control emotional traits such as impulsivity and anxiety, which predispose individuals to addiction. In addition, Dr. Leibowitz has pioneered investigations into prenatal programming—studying how maternal substance use affects offspring neurodevelopment and behavior. Her career has been marked by interdisciplinary collaborations, significant grant support, and mentoring emerging scientists. Dr. Leibowitz’s extensive lab-based research experience has positioned her at the forefront of studies on addiction vulnerability, making meaningful contributions to both basic neuroscience and potential clinical applications.

Awards and Honors

While specific awards and honors for Dr. Sarah F. Leibowitz are not publicly detailed, her long-standing appointment at The Rockefeller University—a prestigious research institution—attests to her outstanding contributions in behavioral neurobiology. Recognition in the scientific community is reflected through her published research, influential collaborations, and leadership in addiction-related neuroscience. She is frequently cited in peer-reviewed journals, indicating strong academic impact and recognition from fellow researchers. Her studies addressing prenatal influences on addiction vulnerability have garnered widespread attention in developmental neuroscience and public health sectors. In addition to academic merit, Dr. Leibowitz’s role as a mentor and educator suggests acknowledgment of her commitment to training the next generation of scientists. The significance and longevity of her research position imply that she has received competitive research funding and peer-reviewed grants, further recognizing the value of her work in advancing understanding of substance use disorders.

Research Focus

Dr. Leibowitz’s research focuses on the neurobiological mechanisms underlying addiction, particularly the transition from use to dependence on substances like alcohol, nicotine, and palatable foods. Her laboratory investigates how neurochemical pathways in various brain regions drive compulsive consumption and are influenced by traits such as novelty seeking, impulsivity, and anxiety. A major area of her research explores the developmental origins of addiction: how maternal consumption of drugs or high-fat/high-sugar diets during pregnancy alters brain development and long-term behavior in offspring. These studies reveal that such prenatal exposures can “reprogram” the brain, increasing susceptibility to substance use disorders in adolescence and adulthood. Through rodent models, Dr. Leibowitz aims to identify biomarkers and early-life predictors of addiction risk, as well as investigate potential interventions for prevention. Her multidisciplinary approach integrates behavioral neuroscience, endocrinology, and developmental biology, contributing valuable insights into addiction’s origins, progression, and possible prevention strategies.

Publications

Title: Neurological Disorders Induced by Drug Use: Effects of Adolescent and Embryonic Drug Exposure on Behavioral Neurodevelopment
Year: 2024
Citations: 2

Title: Utility of the Zebrafish Model for Studying Neuronal and Behavioral Disturbances Induced by Embryonic Exposure to Alcohol, Nicotine, and Cannabis
Year: 2023
Citations: 8

Title: Role of Chemokine Cxcl12a in Mediating the Stimulatory Effects of Ethanol on Embryonic Development of Subpopulations of Hypocretin/Orexin Neurons and Their Projections
Year: 2023
Citations: 10

Title: Embryonic ethanol exposure induces ectopic Hcrt and MCH neurons outside hypothalamus in rats and zebrafish: Role in ethanol‐induced behavioural disturbances
Year: 2022
Citations: 18

Conclusion

Dr. Sarah F. Leibowitz’s work stands at the intersection of neuroscience, behavior, and developmental biology, providing groundbreaking insights into addiction, prenatal brain development, and preventive strategies for substance use disorders, making her a leading figure in behavioral neurobiology and addiction research.

 

Aila Gareayaghi | Post-traumatic Stress Disorder | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Aila Gareayaghi | Post-traumatic Stress Disorder | Best Researcher Award

Dr. Aila Gareayaghi is a committed psychiatrist based in Kocaeli, Türkiye, with a deep passion for trauma-focused therapy, online psychotherapy, and mood and anxiety disorders. She holds the position of Lecturer and Psychiatrist at Kocaeli University and serves as Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye. Dr. Gareayaghi’s extensive clinical and academic work includes innovative research on telepsychiatry, particularly in post-disaster mental health following Türkiye’s 2023 Kahramanmaraş Earthquakes. Her international experience includes a clerkship at Johns Hopkins University, Maryland. Beyond her clinical practice, she is active in research, conference presentations, and has authored multiple peer-reviewed publications addressing PTSD, sexual dysfunction, and transphobia in healthcare. Dr. Gareayaghi is multilingual, speaks advanced English and elementary French, and is a passionate advocate for volunteerism, animal welfare, and nature conservation, integrating her holistic outlook into her psychiatric practice.

Profile

🎓 Education

Dr. Aila Gareayaghi began her academic journey with a High School Diploma from Matthew McNair Secondary School in Vancouver, Canada (2012). She earned her Doctor of Medicine (M.D.) from Bezmialem Vakıf University, Istanbul, Türkiye (2012-2018), where she built a strong foundation in medical sciences. During her medical training, she completed a prestigious clerkship in Gastroenterology at Johns Hopkins University, USA (2018), gaining international exposure to advanced clinical practices. Pursuing her passion for mental health, she specialized in Psychiatry at Kocaeli University, Türkiye (2020-2024). Under the mentorship of Prof. Dr. Elif Tatlıdil, she completed her thesis on “Telepsychiatry Services During the February 6 Earthquakes and PTSD Prevalence Six Months Later.” Additionally, Dr. Gareayaghi continuously expanded her expertise through numerous certifications in psychotherapy, cognitive behavioral therapy, dynamic psychotherapy, EMDR, and traditional Chinese medicine, emphasizing her dedication to comprehensive psychiatric care.

🧪 Experience

Dr. Gareayaghi’s professional experience reflects a blend of clinical practice, teaching, and research. She currently serves as Lecturer and Psychiatrist at the Department of Psychiatry, Kocaeli University (2024–Present), where she actively treats patients, mentors students, and conducts impactful research. As Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye, she plays a leadership role in advancing psychiatric practice and policy at the regional level. Her experience extends internationally, having completed a clinical clerkship in Gastroenterology at Johns Hopkins University, USA. Dr. Gareayaghi has presented her research extensively at national and international psychiatric congresses, covering topics from disaster psychiatry to psychosis and caregiver support. Her work demonstrates strong expertise in trauma therapy, online psychotherapy, and managing complex psychiatric conditions. She is also a prolific contributor to academic literature, authoring multiple peer-reviewed articles and book chapters addressing psychiatric emergencies and psychological trauma interventions.

🏅 Awards and Honors

Dr. Aila Gareayaghi has distinguished herself through numerous scientific contributions and recognitions. She has been invited as a speaker at prestigious forums such as the 59th National Psychiatry Congress and the Symposium on Disaster and Disaster Management. Her presentations on post-earthquake PTSD, antipsychotic-induced complications, and caregiver support have been recognized for their clinical relevance and academic rigor. Dr. Gareayaghi’s research, including peer-reviewed publications on telepsychiatry and transphobia in healthcare, reflects her innovative approach to contemporary psychiatric challenges. Although formal awards are not specified, her active involvement as Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye and her multiple invited speaker roles demonstrate high professional regard and peer recognition. Moreover, her extensive certifications in psychotherapy modalities underscore her commitment to lifelong learning and excellence in patient care. Her dedication to volunteer work and animal welfare also highlight her compassionate engagement beyond academia.

🔬 Research Focus

Dr. Gareayaghi’s research focuses primarily on trauma-informed care, disaster psychiatry, and telepsychiatry, with a special emphasis on the mental health impact of natural disasters. Her thesis work examined the prevalence of PTSD following Türkiye’s 2023 earthquakes and the effectiveness of telepsychiatry services during disaster recovery. Additionally, her research explores societal and clinical aspects of sexual dysfunction, major depressive disorder, bipolar disorder, schizophrenia, and anxiety disorders. She has published studies addressing transphobia in healthcare, antipsychotic-induced complications, and innovative therapeutic interventions such as EMDR. Dr. Gareayaghi integrates various therapeutic modalities, including dynamic psychotherapy, cognitive behavioral therapy, and psychodynamic psychotherapy, into both her clinical practice and research. Her multidisciplinary approach bridges clinical psychiatry, public health, and social psychology, contributing valuable insights into the management of psychiatric emergencies and the psychological aftermath of crises. Her ongoing work continues to address evolving mental health challenges in both individual and systemic contexts.

✅ Conclusion

Dr. Aila Gareayaghi exemplifies a dynamic psychiatrist integrating clinical excellence, cutting-edge research, and compassionate care, with a focus on trauma therapy, disaster psychiatry, telepsychiatry, and comprehensive psychiatric education.

Publications

  • Ruh Sağlığında Kriz

    ÖGDA GAREAYAGHİ, UDH YILMAZ, A POLAT
    PSİKİYATRİK ACİLLER
  • A MEDICAL STUDENT’S PERSPECTIVE ON ANIMAL EXPERIMENTATION.
    A Gareayaghi
    The Turkish Journal of Gastroenterology: the Official Journal of Turkish …

  • Predictors of Transphobia and Attitudes Toward Transgender Individuals Among Nurses in Türkiye: A Cross-Sectional Study

    Healthcare
    2025-06-19 | Journal article
    DOI: 10.3390/healthcare13121474
    CONTRIBUTORS: Ezgi Şişman; Mehtap Güngör; Aila Gareayaghi; Hanife Yılmaz; Aslıhan Polat

  • Post-Earthquake PTSD and the Role of Telepsychiatry: A Six-Month Follow-Up Study After the 2023 Kahramanmaraş Earthquakes

    Medicina
    2025-06-17 | Journal article
    DOI: 10.3390/medicina61061097
    CONTRIBUTORS: Aila Gareayaghi; Elif Tatlıdil; Ezgi Şişman; Aslıhan Polat

  • Experiences with Brexpiprazole in the Management of Agitation Due to Dementia in a University Clinic: A Case Series

    Kocaeli Üniversitesi Sağlık Bilimleri Dergisi
    2025-03-21 | Journal article
    DOI: 10.30934/kusbed.1617807
    CONTRIBUTORS: Aila Gareayaghi; Ezgi Şişman; Mert Türksoy; Aslıhan Özlem Polat Işık

Dyandevi mathure | Nanoformulation for Alzheimer’s disease | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Dyandevi mathure | Nanoformulation for Alzheimer’s disease | Best Researcher Award

Dr. Dyandevi Mewalal Mathure, Assistant Professor at Bharati Vidyapeeth, Poona College of Pharmacy, Pune, is a distinguished academician with over 15 years of experience in pharmaceutical sciences. Holding a Ph.D. in Pharmaceutical Sciences, she has significantly contributed to teaching, research, and innovation. Dr. Mathure has authored three notable books, published 18 research articles in reputed journals, and holds five published patents. Her research primarily focuses on nanoformulations for Alzheimer’s disease, wound healing, and topical formulations for skin diseases. She has successfully completed government-funded research projects and is actively engaged in industry consultancy work. Collaborating with institutions like the University of Petroleum and Energy Studies, Dehradun, Dr. Mathure continues to push the frontiers of pharmaceutical research. Her dedication is reflected in multiple accolades, including best paper presentation awards at international conferences. Committed to translational pharmaceutical advancements, she remains a passionate contributor to academia and industry alike.

Profile

🎓 Education

Dr. Dyandevi Mewalal Mathure earned her Ph.D. in Pharmaceutical Sciences, building a robust foundation in pharmaceutical research and innovation. Her academic journey has been characterized by a strong emphasis on novel drug delivery systems, formulation development, and translational research. She has engaged in continuous professional development, authoring several key texts in Industrial Pharmacy and Modern Dispensing Practices, which are widely used in academic curricula. Her educational background not only reflects depth in pharmaceutical sciences but also showcases her commitment to knowledge dissemination through teaching and publication. Her advanced training and research expertise in nanoformulations, brain-targeted drug delivery, and topical therapeutic systems underscore her position as a subject matter expert. Dr. Mathure’s education has enabled her to bridge theory and practice, equipping her with the skills to lead significant research projects, collaborate with industry partners, and mentor future pharmacists and researchers.

🧪 Experience

With over 15 years of academic and research experience, Dr. Dyandevi Mewalal Mathure has built a distinguished career as an Assistant Professor at Bharati Vidyapeeth, Poona College of Pharmacy, Pune. Her professional journey encompasses extensive teaching, research supervision, and collaborative research projects. She has published 18 papers in esteemed SCI and Scopus-indexed journals, authored three textbooks, and successfully filed five patents. Dr. Mathure has completed one funded research project and is currently engaged in an ongoing industry consultancy project, demonstrating her ability to translate academic research into practical applications. Her collaborations with institutions like the University of Petroleum and Energy Studies highlight her commitment to multidisciplinary research. Additionally, her expertise in nanoformulations for Alzheimer’s disease, wound healing, and skin disorders reflects her diverse research interests. Through her dedicated mentorship and active participation in international conferences, she continues to inspire and guide students, contributing significantly to the advancement of pharmaceutical sciences.

🏅 Awards and Honors

Dr. Dyandevi Mewalal Mathure has been recognized for her outstanding research contributions through multiple awards and honors. Notably, she received the Best Paper Presentation Award at the international e-Conference on “Expanding Frontier of Pharmaceutical Research Towards Global Exigency,” organized by Karpagam College of Pharmacy in association with the Indian Pharmaceutical Association, Coimbatore Branch. Her consistent scholarly excellence is reflected in her extensive publication record and successful patent filings. Dr. Mathure’s innovative work has garnered appreciation from both academia and industry, enhancing her reputation as a leader in pharmaceutical research. In addition to her academic accolades, her active involvement in consultancy projects further validates the real-world impact of her research. Her sustained commitment to innovation, teaching excellence, and translational research has made her a strong contender for the Best Research Award, recognizing her as a role model in the field of pharmaceutical sciences.

🔬 Research Focus

Dr. Dyandevi Mewalal Mathure’s research focuses on developing advanced nanoformulations aimed at treating Alzheimer’s disease, promoting wound healing, and addressing various dermatological conditions through innovative topical formulations. Her work emphasizes the design and optimization of novel drug delivery systems that enhance therapeutic efficacy and patient compliance. Through her publications, patents, and consultancy projects, Dr. Mathure has contributed to the advancement of brain-targeted drug delivery, an area critical for managing neurodegenerative diseases. Her translational research bridges laboratory discoveries with clinical and industrial applications, offering practical solutions to complex medical challenges. Collaborations with reputed institutions like UPES Dehradun further demonstrate her commitment to multidisciplinary and applied pharmaceutical research. With a citation index of 6, she maintains an active presence in scientific discourse, continuously advancing the boundaries of pharmaceutical sciences. Her work exemplifies innovation-driven research with tangible societal impact.

✅ Conclusion

Dr. Dyandevi Mewalal Mathure’s distinguished academic career, marked by impactful research in nanoformulations, drug delivery, numerous publications, patents, and active industry collaborations, demonstrates her unwavering commitment to advancing pharmaceutical sciences and improving patient care through innovation and translational research.

Publications